HALOZYME Q3 2025 TL;DR
Financial Highlights: The company delivered strong growth in Q3 2025, reporting \(354.3M in revenue (+22% YoY) and Diluted EPS of \)1.43. Nine-month (9M) performance was robust: Total Revenue reached \(944.8M (up 31.7% YoY), Net Income climbed 49% to \)458.5M, and Diluted EPS hit \(3.68. Royalties were the primary driver, totaling \)609.9M for 9M, boosted by VYVGART, DARZALEX SC, and Phesgo uptake.
Strategic Transactions & Operations: Halozyme announced the intent to acquire Elektrofi, Inc. for an upfront payment of $750 million plus milestones, expected to close
...